(390g) A Systems Biology Approach to Identify Immune Targets That Control Tuberculosis Granuloma Function
AIChE Annual Meeting
2011
2011 Annual Meeting
Systems Biology
Modeling Approaches In the Life Sciences II
Tuesday, October 18, 2011 - 4:51pm to 5:07pm
Tuberculosis (TB) is a common and deadly infectious disease caused by a highly successful bacterium, Mycobacterium tuberculosis (Mtb). Multiple host immune factors control the formation of a self-organizing aggregate of immune cells termed a granuloma, after inhalation of Mtb. One such factor, tumor necrosis factor-α (TNF), is a protein that regulates inflammatory immune responses. TNF (in conjunction with the cytokine IFN-γ) induces macrophage activation, enhances immune cell recruitment to the site of infection, and augments chemokine and cytokine expression by macrophages through activation of the NF-κB signaling pathway. However, there are differences among dynamics of each of these NF-κB-associated responses as a result of differences in molecular processes (e.g. RNA and protein degradation rates) acting downstream of TNF-induced NF-κB activation. The impact of these dynamical differences on formation and function of granulomas and thus the outcome of Mtb infection is not known.
We have developed a multi-scale computational model that describes the immune response to Mtb in lung over three biological length scales: tissue, cellular and molecular. Using this model, we predict the impact of NF-κB associated response dynamics on the outcome of infection at the level of a granuloma. Our model suggests that the timing of these responses, in addition to the extent of response, plays a critical role in control of infection and inflammation. Manipulations of the dynamics of these responses lead to different outcomes, including clearance of bacteria, containment of bacteria within a stable granuloma, uncontrolled growth of bacteria, or excessive inflammation. The intracellular NF-κB associated signaling molecules and processes involved in TB immunity that we identify as crucial may be new targets for therapy.